Brandinium

Trademark search for:

ENDORECUR

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2011-11-23 — Application filed
  • 2011-11-26 — Application filed
  • 2011-12-01 — Application filed
  • 2011-12-02 — Notice of pseudo mark mailed
  • 2012-02-28 — Assigned to examiner
  • 2012-03-03 — Approved for pub - principal register
  • 2012-03-21 — Assigned to lie
  • 2012-03-23 — Law office publication review completed
  • 2012-04-11 — Notification of notice of publication e-mailed
  • 2012-05-01 — Published for opposition
  • 2012-05-01 — Official gazette publication confirmation e-mailed
  • 2012-07-17 — Registered-principal register
  • 2017-07-17 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2019-02-22 — Cancelled sec. 8 (6-yr)
  • 2019-02-22 — Final status recorded

Owner Information

OvaGene Oncology, Inc.
Irvine , CA
OvaGene Oncology, Inc.
Irvine , CA
OvaGene Oncology, Inc.
Irvine , CA

Correspondent

KEVIN E. NOONAN MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP
300 S WACKER DR FL 32D
CHICAGO, IL 60606-6680
UNITED STATES

Filing Details

Filing Date:
2011-11-23
Status Date:
2019-02-22
Filing Year:
2011

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.